ENOA_HUMAN - dbPTM
ENOA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ENOA_HUMAN
UniProt AC P06733
Protein Name Alpha-enolase
Gene Name ENO1
Organism Homo sapiens (Human).
Sequence Length 434
Subcellular Localization Cytoplasm . Cell membrane . Cytoplasm, myofibril, sarcomere, M line . Can translocate to the plasma membrane in either the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form. ENO1 is localized to the M line.
Isoform MBP-1: Nucleus.
Protein Description Multifunctional enzyme that, as well as its role in glycolysis, plays a part in various processes such as growth control, hypoxia tolerance and allergic responses. May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons. Stimulates immunoglobulin production.; MBP1 binds to the myc promoter and acts as a transcriptional repressor. May be a tumor suppressor..
Protein Sequence MSILKIHAREIFDSRGNPTVEVDLFTSKGLFRAAVPSGASTGIYEALELRDNDKTRYMGKGVSKAVEHINKTIAPALVSKKLNVTEQEKIDKLMIEMDGTENKSKFGANAILGVSLAVCKAGAVEKGVPLYRHIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFREAMRIGAEVYHNLKNVIKEKYGKDATNVGDEGGFAPNILENKEGLELLKTAIGKAGYTDKVVIGMDVAASEFFRSGKYDLDFKSPDDPSRYISPDQLADLYKSFIKDYPVVSIEDPFDQDDWGAWQKFTASAGIQVVGDDLTVTNPKRIAKAVNEKSCNCLLLKVNQIGSVTESLQACKLAQANGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLLRIEEELGSKAKFAGRNFRNPLAK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSILKIHAR
------CCCEEEEEH
36.3125944712
2Phosphorylation------MSILKIHAR
------CCCEEEEEH
36.3124719451
52-Hydroxyisobutyrylation---MSILKIHAREIF
---CCCEEEEEHHHH
30.67-
5Acetylation---MSILKIHAREIF
---CCCEEEEEHHHH
30.6719608861
5Malonylation---MSILKIHAREIF
---CCCEEEEEHHHH
30.6726320211
5Succinylation---MSILKIHAREIF
---CCCEEEEEHHHH
30.6723954790
5Ubiquitination---MSILKIHAREIF
---CCCEEEEEHHHH
30.6721890473
5Ubiquitination---MSILKIHAREIF
---CCCEEEEEHHHH
30.6721890473
5Ubiquitination---MSILKIHAREIF
---CCCEEEEEHHHH
30.6721890473
9MethylationSILKIHAREIFDSRG
CCEEEEEHHHHHCCC
24.31-
10 (in isoform 2)Ubiquitination-49.11-
14PhosphorylationHAREIFDSRGNPTVE
EEHHHHHCCCCCEEE
31.1921815630
15MethylationAREIFDSRGNPTVEV
EHHHHHCCCCCEEEE
51.24-
19PhosphorylationFDSRGNPTVEVDLFT
HHCCCCCEEEEEEEC
33.0430624053
26PhosphorylationTVEVDLFTSKGLFRA
EEEEEEECCCCCHHE
36.5030266825
27PhosphorylationVEVDLFTSKGLFRAA
EEEEEECCCCCHHEE
19.8630266825
27 (in isoform 2)Ubiquitination-19.8621890473
28AcetylationEVDLFTSKGLFRAAV
EEEEECCCCCHHEEC
57.4823954790
28UbiquitinationEVDLFTSKGLFRAAV
EEEEECCCCCHHEEC
57.4821890473
28 (in isoform 1)Ubiquitination-57.4821890473
28UbiquitinationEVDLFTSKGLFRAAV
EEEEECCCCCHHEEC
57.4821890473
28UbiquitinationEVDLFTSKGLFRAAV
EEEEECCCCCHHEEC
57.4821890473
33AcetylationTSKGLFRAAVPSGAS
CCCCCHHEECCCCCC
12.8919608861
33UbiquitinationTSKGLFRAAVPSGAS
CCCCCHHEECCCCCC
12.8919608861
33 (in isoform 2)Ubiquitination-12.8921890473
37PhosphorylationLFRAAVPSGASTGIY
CHHEECCCCCCCCHH
40.1521945579
40PhosphorylationAAVPSGASTGIYEAL
EECCCCCCCCHHHHH
30.6029255136
41PhosphorylationAVPSGASTGIYEALE
ECCCCCCCCHHHHHH
27.3721945579
44PhosphorylationSGASTGIYEALELRD
CCCCCCHHHHHHCCC
9.1129255136
50MethylationIYEALELRDNDKTRY
HHHHHHCCCCCCCCC
31.17-
54AcetylationLELRDNDKTRYMGKG
HHCCCCCCCCCCCCC
40.9523236377
54UbiquitinationLELRDNDKTRYMGKG
HHCCCCCCCCCCCCC
40.9521890473
54 (in isoform 1)Ubiquitination-40.9521890473
54UbiquitinationLELRDNDKTRYMGKG
HHCCCCCCCCCCCCC
40.9521890473
54UbiquitinationLELRDNDKTRYMGKG
HHCCCCCCCCCCCCC
40.9521890473
55PhosphorylationELRDNDKTRYMGKGV
HCCCCCCCCCCCCCH
29.8728857561
57PhosphorylationRDNDKTRYMGKGVSK
CCCCCCCCCCCCHHH
18.5622817900
602-HydroxyisobutyrylationDKTRYMGKGVSKAVE
CCCCCCCCCHHHHHH
39.34-
60AcetylationDKTRYMGKGVSKAVE
CCCCCCCCCHHHHHH
39.3419608861
60SuccinylationDKTRYMGKGVSKAVE
CCCCCCCCCHHHHHH
39.34-
60SuccinylationDKTRYMGKGVSKAVE
CCCCCCCCCHHHHHH
39.3423954790
60UbiquitinationDKTRYMGKGVSKAVE
CCCCCCCCCHHHHHH
39.3419608861
60 (in isoform 1)Ubiquitination-39.3421890473
63PhosphorylationRYMGKGVSKAVEHIN
CCCCCCHHHHHHHHH
24.4628857561
64AcetylationYMGKGVSKAVEHINK
CCCCCHHHHHHHHHH
54.7919608861
64UbiquitinationYMGKGVSKAVEHINK
CCCCCHHHHHHHHHH
54.7919608861
64 (in isoform 1)Ubiquitination-54.7921890473
64UbiquitinationYMGKGVSKAVEHINK
CCCCCHHHHHHHHHH
54.7921890473
64UbiquitinationYMGKGVSKAVEHINK
CCCCCHHHHHHHHHH
54.7921890473
712-HydroxyisobutyrylationKAVEHINKTIAPALV
HHHHHHHHCHHHHHH
40.48-
71AcetylationKAVEHINKTIAPALV
HHHHHHHHCHHHHHH
40.4819608861
71MalonylationKAVEHINKTIAPALV
HHHHHHHHCHHHHHH
40.4826320211
71UbiquitinationKAVEHINKTIAPALV
HHHHHHHHCHHHHHH
40.4821890473
71 (in isoform 1)Ubiquitination-40.4821890473
71UbiquitinationKAVEHINKTIAPALV
HHHHHHHHCHHHHHH
40.4821890473
71UbiquitinationKAVEHINKTIAPALV
HHHHHHHHCHHHHHH
40.4821890473
72PhosphorylationAVEHINKTIAPALVS
HHHHHHHCHHHHHHH
20.2022617229
79PhosphorylationTIAPALVSKKLNVTE
CHHHHHHHHCCCCCC
25.5623401153
802-HydroxyisobutyrylationIAPALVSKKLNVTEQ
HHHHHHHHCCCCCCH
54.52-
80AcetylationIAPALVSKKLNVTEQ
HHHHHHHHCCCCCCH
54.5223954790
80MalonylationIAPALVSKKLNVTEQ
HHHHHHHHCCCCCCH
54.5226320211
80UbiquitinationIAPALVSKKLNVTEQ
HHHHHHHHCCCCCCH
54.5221906983
80 (in isoform 1)Ubiquitination-54.5221890473
80UbiquitinationIAPALVSKKLNVTEQ
HHHHHHHHCCCCCCH
54.5221890473
80UbiquitinationIAPALVSKKLNVTEQ
HHHHHHHHCCCCCCH
54.5221890473
812-HydroxyisobutyrylationAPALVSKKLNVTEQE
HHHHHHHCCCCCCHH
37.47-
81AcetylationAPALVSKKLNVTEQE
HHHHHHHCCCCCCHH
37.4720433201
81MalonylationAPALVSKKLNVTEQE
HHHHHHHCCCCCCHH
37.4726320211
81UbiquitinationAPALVSKKLNVTEQE
HHHHHHHCCCCCCHH
37.47-
81 (in isoform 1)Ubiquitination-37.4721890473
85PhosphorylationVSKKLNVTEQEKIDK
HHHCCCCCCHHHHHH
30.7726437602
89AcetylationLNVTEQEKIDKLMIE
CCCCCHHHHHHHEEE
56.7719608861
89SuccinylationLNVTEQEKIDKLMIE
CCCCCHHHHHHHEEE
56.77-
89SuccinylationLNVTEQEKIDKLMIE
CCCCCHHHHHHHEEE
56.7727452117
89UbiquitinationLNVTEQEKIDKLMIE
CCCCCHHHHHHHEEE
56.7719608861
89 (in isoform 1)Ubiquitination-56.7721890473
92AcetylationTEQEKIDKLMIEMDG
CCHHHHHHHEEECCC
43.3523954790
92UbiquitinationTEQEKIDKLMIEMDG
CCHHHHHHHEEECCC
43.3521906983
92 (in isoform 1)Ubiquitination-43.3521890473
94SulfoxidationQEKIDKLMIEMDGTE
HHHHHHHEEECCCCC
2.7621406390
97SulfoxidationIDKLMIEMDGTENKS
HHHHEEECCCCCCCH
3.8928465586
100AcetylationLMIEMDGTENKSKFG
HEEECCCCCCCHHHC
31.9219608861
100PhosphorylationLMIEMDGTENKSKFG
HEEECCCCCCCHHHC
31.9220068231
100UbiquitinationLMIEMDGTENKSKFG
HEEECCCCCCCHHHC
31.9219608861
100 (in isoform 2)Ubiquitination-31.9221890473
1032-HydroxyisobutyrylationEMDGTENKSKFGANA
ECCCCCCCHHHCHHH
49.11-
103AcetylationEMDGTENKSKFGANA
ECCCCCCCHHHCHHH
49.1120433201
103UbiquitinationEMDGTENKSKFGANA
ECCCCCCCHHHCHHH
49.1121906983
103 (in isoform 1)Ubiquitination-49.1121890473
104PhosphorylationMDGTENKSKFGANAI
CCCCCCCHHHCHHHH
44.8128857561
105AcetylationDGTENKSKFGANAIL
CCCCCCHHHCHHHHH
49.8020433201
105UbiquitinationDGTENKSKFGANAIL
CCCCCCHHHCHHHHH
49.80-
106AcetylationGTENKSKFGANAILG
CCCCCHHHCHHHHHH
16.8219608861
109 (in isoform 2)Ubiquitination-28.0821890473
115PhosphorylationANAILGVSLAVCKAG
HHHHHHHHHHHHHHC
14.60-
119S-palmitoylationLGVSLAVCKAGAVEK
HHHHHHHHHHCHHHC
1.7629575903
120UbiquitinationGVSLAVCKAGAVEKG
HHHHHHHHHCHHHCC
43.1721906983
120 (in isoform 1)Ubiquitination-43.1721890473
126AcetylationCKAGAVEKGVPLYRH
HHHCHHHCCCCCHHH
59.6219608861
126MalonylationCKAGAVEKGVPLYRH
HHHCHHHCCCCCHHH
59.6226320211
126UbiquitinationCKAGAVEKGVPLYRH
HHHCHHHCCCCCHHH
59.6221890473
126 (in isoform 1)Ubiquitination-59.6221890473
128AcetylationAGAVEKGVPLYRHIA
HCHHHCCCCCHHHHH
4.3519608861
128UbiquitinationAGAVEKGVPLYRHIA
HCHHHCCCCCHHHHH
4.3519608861
128 (in isoform 2)Ubiquitination-4.3521890473
131PhosphorylationVEKGVPLYRHIADLA
HHCCCCCHHHHHHHC
8.2826356563
135AcetylationVPLYRHIADLAGNSE
CCCHHHHHHHCCCCE
10.3119608861
135UbiquitinationVPLYRHIADLAGNSE
CCCHHHHHHHCCCCE
10.3119608861
135 (in isoform 2)Ubiquitination-10.3121890473
140AcetylationHIADLAGNSEVILPV
HHHHHCCCCEEEEEE
29.4119608861
140UbiquitinationHIADLAGNSEVILPV
HHHHHCCCCEEEEEE
29.4119608861
140 (in isoform 2)Ubiquitination-29.4121890473
141PhosphorylationIADLAGNSEVILPVP
HHHHCCCCEEEEEEC
32.1128450419
157PhosphorylationFNVINGGSHAGNKLA
EEEECCCCCCCCHHH
16.1528450419
163AcetylationGSHAGNKLAMQEFMI
CCCCCCHHHHCEECE
5.7919608861
163UbiquitinationGSHAGNKLAMQEFMI
CCCCCCHHHHCEECE
5.7919608861
163 (in isoform 2)Ubiquitination-5.7921890473
165SulfoxidationHAGNKLAMQEFMILP
CCCCHHHHCEECEEC
5.9421406390
169SulfoxidationKLAMQEFMILPVGAA
HHHHCEECEECCCHH
2.7930846556
169 (in isoform 2)Ubiquitination-2.7921890473
183MethylationANFREAMRIGAEVYH
HHHHHHHHHCHHHHH
31.10-
188AcetylationAMRIGAEVYHNLKNV
HHHHCHHHHHHHHHH
6.1319608861
188UbiquitinationAMRIGAEVYHNLKNV
HHHHCHHHHHHHHHH
6.1319608861
188 (in isoform 2)Ubiquitination-6.1321890473
189PhosphorylationMRIGAEVYHNLKNVI
HHHCHHHHHHHHHHH
4.0521712546
192AcetylationGAEVYHNLKNVIKEK
CHHHHHHHHHHHHHH
2.4519608861
192UbiquitinationGAEVYHNLKNVIKEK
CHHHHHHHHHHHHHH
2.4519608861
192 (in isoform 2)Ubiquitination-2.4521890473
1932-HydroxyisobutyrylationAEVYHNLKNVIKEKY
HHHHHHHHHHHHHHH
55.26-
193AcetylationAEVYHNLKNVIKEKY
HHHHHHHHHHHHHHH
55.2619608861
193MalonylationAEVYHNLKNVIKEKY
HHHHHHHHHHHHHHH
55.2626320211
193UbiquitinationAEVYHNLKNVIKEKY
HHHHHHHHHHHHHHH
55.2621890473
193 (in isoform 1)Ubiquitination-55.2621890473
193UbiquitinationAEVYHNLKNVIKEKY
HHHHHHHHHHHHHHH
55.2621890473
193UbiquitinationAEVYHNLKNVIKEKY
HHHHHHHHHHHHHHH
55.2621890473
197AcetylationHNLKNVIKEKYGKDA
HHHHHHHHHHHCCCC
43.8226051181
197UbiquitinationHNLKNVIKEKYGKDA
HHHHHHHHHHHCCCC
43.8222053931
199AcetylationLKNVIKEKYGKDATN
HHHHHHHHHCCCCCC
55.0619608861
199UbiquitinationLKNVIKEKYGKDATN
HHHHHHHHHCCCCCC
55.0619608861
200PhosphorylationKNVIKEKYGKDATNV
HHHHHHHHCCCCCCC
30.4228152594
202AcetylationVIKEKYGKDATNVGD
HHHHHHCCCCCCCCC
40.8923954790
202MalonylationVIKEKYGKDATNVGD
HHHHHHCCCCCCCCC
40.8926320211
202SumoylationVIKEKYGKDATNVGD
HHHHHHCCCCCCCCC
40.8928112733
202UbiquitinationVIKEKYGKDATNVGD
HHHHHHCCCCCCCCC
40.89-
202 (in isoform 1)Ubiquitination-40.8921890473
205PhosphorylationEKYGKDATNVGDEGG
HHHCCCCCCCCCCCC
40.3428152594
2212-HydroxyisobutyrylationAPNILENKEGLELLK
CCCHHCCHHHHHHHH
43.73-
221AcetylationAPNILENKEGLELLK
CCCHHCCHHHHHHHH
43.7323954790
221SuccinylationAPNILENKEGLELLK
CCCHHCCHHHHHHHH
43.7323954790
221SumoylationAPNILENKEGLELLK
CCCHHCCHHHHHHHH
43.7319608861
221UbiquitinationAPNILENKEGLELLK
CCCHHCCHHHHHHHH
43.7321890473
221 (in isoform 1)Ubiquitination-43.7321890473
221UbiquitinationAPNILENKEGLELLK
CCCHHCCHHHHHHHH
43.7321890473
221UbiquitinationAPNILENKEGLELLK
CCCHHCCHHHHHHHH
43.7321890473
2282-HydroxyisobutyrylationKEGLELLKTAIGKAG
HHHHHHHHHHHHHCC
48.84-
228AcetylationKEGLELLKTAIGKAG
HHHHHHHHHHHHHCC
48.8419608861
228OtherKEGLELLKTAIGKAG
HHHHHHHHHHHHHCC
48.8429775581
228SuccinylationKEGLELLKTAIGKAG
HHHHHHHHHHHHHCC
48.84-
228SuccinylationKEGLELLKTAIGKAG
HHHHHHHHHHHHHCC
48.8423954790
228UbiquitinationKEGLELLKTAIGKAG
HHHHHHHHHHHHHCC
48.8419608861
228 (in isoform 1)Ubiquitination-48.8421890473
229PhosphorylationEGLELLKTAIGKAGY
HHHHHHHHHHHHCCC
24.3928857561
233N6-malonyllysineLLKTAIGKAGYTDKV
HHHHHHHHCCCCCEE
32.31-
2332-HydroxyisobutyrylationLLKTAIGKAGYTDKV
HHHHHHHHCCCCCEE
32.31-
233AcetylationLLKTAIGKAGYTDKV
HHHHHHHHCCCCCEE
32.3119608861
233MalonylationLLKTAIGKAGYTDKV
HHHHHHHHCCCCCEE
32.3126320211
233UbiquitinationLLKTAIGKAGYTDKV
HHHHHHHHCCCCCEE
32.3121890473
233 (in isoform 1)Ubiquitination-32.3121890473
233 (in isoform 2)Ubiquitination-32.3121890473
233UbiquitinationLLKTAIGKAGYTDKV
HHHHHHHHCCCCCEE
32.3121890473
233UbiquitinationLLKTAIGKAGYTDKV
HHHHHHHHCCCCCEE
32.3121890473
236NitrationTAIGKAGYTDKVVIG
HHHHHCCCCCEEEEC
19.34-
236PhosphorylationTAIGKAGYTDKVVIG
HHHHHCCCCCEEEEC
19.3419835603
237PhosphorylationAIGKAGYTDKVVIGM
HHHHCCCCCEEEECE
28.5519835603
2392-HydroxyisobutyrylationGKAGYTDKVVIGMDV
HHCCCCCEEEECEEH
30.51-
239AcetylationGKAGYTDKVVIGMDV
HHCCCCCEEEECEEH
30.5120433201
239UbiquitinationGKAGYTDKVVIGMDV
HHCCCCCEEEECEEH
30.51-
242 (in isoform 2)Ubiquitination-4.1821890473
244SulfoxidationTDKVVIGMDVAASEF
CCEEEECEEHHHHHH
2.2921406390
249PhosphorylationIGMDVAASEFFRSGK
ECEEHHHHHHHHCCC
25.7929514088
250AcetylationGMDVAASEFFRSGKY
CEEHHHHHHHHCCCC
44.0419608861
250UbiquitinationGMDVAASEFFRSGKY
CEEHHHHHHHHCCCC
44.0419608861
250 (in isoform 2)Ubiquitination-44.0421890473
254PhosphorylationAASEFFRSGKYDLDF
HHHHHHHCCCCCCCC
34.1823401153
2562-HydroxyisobutyrylationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.52-
256AcetylationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.5219608861
256MalonylationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.5226320211
256MethylationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.5219608861
256SumoylationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.5219608861
256UbiquitinationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.5221890473
256 (in isoform 1)Ubiquitination-36.5221890473
256UbiquitinationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.5221890473
256UbiquitinationSEFFRSGKYDLDFKS
HHHHHCCCCCCCCCC
36.5221890473
257PhosphorylationEFFRSGKYDLDFKSP
HHHHCCCCCCCCCCC
25.8430266825
2622-HydroxyisobutyrylationGKYDLDFKSPDDPSR
CCCCCCCCCCCCHHH
61.82-
262AcetylationGKYDLDFKSPDDPSR
CCCCCCCCCCCCHHH
61.8220433201
262SuccinylationGKYDLDFKSPDDPSR
CCCCCCCCCCCCHHH
61.8223954790
262SumoylationGKYDLDFKSPDDPSR
CCCCCCCCCCCCHHH
61.82-
262UbiquitinationGKYDLDFKSPDDPSR
CCCCCCCCCCCCHHH
61.8221890473
262 (in isoform 1)Ubiquitination-61.8221890473
262UbiquitinationGKYDLDFKSPDDPSR
CCCCCCCCCCCCHHH
61.8221890473
262UbiquitinationGKYDLDFKSPDDPSR
CCCCCCCCCCCCHHH
61.8221890473
263PhosphorylationKYDLDFKSPDDPSRY
CCCCCCCCCCCHHHC
33.2922167270
268PhosphorylationFKSPDDPSRYISPDQ
CCCCCCHHHCCCHHH
44.7221945579
270PhosphorylationSPDDPSRYISPDQLA
CCCCHHHCCCHHHHH
15.3021945579
272PhosphorylationDDPSRYISPDQLADL
CCHHHCCCHHHHHHH
17.3123927012
280PhosphorylationPDQLADLYKSFIKDY
HHHHHHHHHHHHCCC
12.7221945579
2812-HydroxyisobutyrylationDQLADLYKSFIKDYP
HHHHHHHHHHHCCCC
46.30-
281AcetylationDQLADLYKSFIKDYP
HHHHHHHHHHHCCCC
46.3019608861
281OtherDQLADLYKSFIKDYP
HHHHHHHHHHHCCCC
46.3029775581
281SuccinylationDQLADLYKSFIKDYP
HHHHHHHHHHHCCCC
46.3023954790
281UbiquitinationDQLADLYKSFIKDYP
HHHHHHHHHHHCCCC
46.3021890473
281 (in isoform 1)Ubiquitination-46.3021890473
281UbiquitinationDQLADLYKSFIKDYP
HHHHHHHHHHHCCCC
46.3021890473
281UbiquitinationDQLADLYKSFIKDYP
HHHHHHHHHHHCCCC
46.3021890473
282PhosphorylationQLADLYKSFIKDYPV
HHHHHHHHHHCCCCE
20.7422617229
285AcetylationDLYKSFIKDYPVVSI
HHHHHHHCCCCEEEE
49.5519608861
285MethylationDLYKSFIKDYPVVSI
HHHHHHHCCCCEEEE
49.5519608861
285SuccinylationDLYKSFIKDYPVVSI
HHHHHHHCCCCEEEE
49.5523954790
285UbiquitinationDLYKSFIKDYPVVSI
HHHHHHHCCCCEEEE
49.5519608861
285 (in isoform 1)Ubiquitination-49.5521890473
287PhosphorylationYKSFIKDYPVVSIED
HHHHHCCCCEEEECC
7.9122115753
291PhosphorylationIKDYPVVSIEDPFDQ
HCCCCEEEECCCCCC
22.0926356563
306AcetylationDDWGAWQKFTASAGI
CCCCHHHHHHHCCCC
33.7070179
308O-linked_GlycosylationWGAWQKFTASAGIQV
CCHHHHHHHCCCCEE
27.09OGP
308PhosphorylationWGAWQKFTASAGIQV
CCHHHHHHHCCCCEE
27.0927050516
310PhosphorylationAWQKFTASAGIQVVG
HHHHHHHCCCCEEEC
24.7825159151
313AcetylationKFTASAGIQVVGDDL
HHHHCCCCEEECCCC
2.5519608861
313UbiquitinationKFTASAGIQVVGDDL
HHHHCCCCEEECCCC
2.5519608861
313 (in isoform 2)Ubiquitination-2.5521890473
321PhosphorylationQVVGDDLTVTNPKRI
EEECCCCEECCHHHH
32.0727251275
323PhosphorylationVGDDLTVTNPKRIAK
ECCCCEECCHHHHHH
40.3427251275
3262-HydroxyisobutyrylationDLTVTNPKRIAKAVN
CCEECCHHHHHHHCC
59.51-
326AcetylationDLTVTNPKRIAKAVN
CCEECCHHHHHHHCC
59.5126051181
326UbiquitinationDLTVTNPKRIAKAVN
CCEECCHHHHHHHCC
59.5121906983
326 (in isoform 1)Ubiquitination-59.5121890473
327AcetylationLTVTNPKRIAKAVNE
CEECCHHHHHHHCCC
35.0419608861
327UbiquitinationLTVTNPKRIAKAVNE
CEECCHHHHHHHCCC
35.0419608861
327 (in isoform 2)Ubiquitination-35.0421890473
3302-HydroxyisobutyrylationTNPKRIAKAVNEKSC
CCHHHHHHHCCCCCC
50.96-
330AcetylationTNPKRIAKAVNEKSC
CCHHHHHHHCCCCCC
50.9620433201
330SuccinylationTNPKRIAKAVNEKSC
CCHHHHHHHCCCCCC
50.9623954790
330UbiquitinationTNPKRIAKAVNEKSC
CCHHHHHHHCCCCCC
50.96-
335AcetylationIAKAVNEKSCNCLLL
HHHHCCCCCCCEEEE
55.9223954790
335PhosphoglycerylationIAKAVNEKSCNCLLL
HHHHCCCCCCCEEEE
55.92-
335UbiquitinationIAKAVNEKSCNCLLL
HHHHCCCCCCCEEEE
55.9221890473
335 (in isoform 1)Ubiquitination-55.9221890473
335UbiquitinationIAKAVNEKSCNCLLL
HHHHCCCCCCCEEEE
55.9221890473
335UbiquitinationIAKAVNEKSCNCLLL
HHHHCCCCCCCEEEE
55.9221890473
336PhosphorylationAKAVNEKSCNCLLLK
HHHCCCCCCCEEEEE
12.3724114839
337S-nitrosylationKAVNEKSCNCLLLKV
HHCCCCCCCEEEEEH
6.542212679
337S-palmitoylationKAVNEKSCNCLLLKV
HHCCCCCCCEEEEEH
6.5429575903
339S-palmitoylationVNEKSCNCLLLKVNQ
CCCCCCCEEEEEHHH
3.1229575903
3432-HydroxyisobutyrylationSCNCLLLKVNQIGSV
CCCEEEEEHHHHCCH
38.82-
343AcetylationSCNCLLLKVNQIGSV
CCCEEEEEHHHHCCH
38.8223954790
343PhosphoglycerylationSCNCLLLKVNQIGSV
CCCEEEEEHHHHCCH
38.82-
343UbiquitinationSCNCLLLKVNQIGSV
CCCEEEEEHHHHCCH
38.8221890473
343 (in isoform 1)Ubiquitination-38.8221890473
343UbiquitinationSCNCLLLKVNQIGSV
CCCEEEEEHHHHCCH
38.8221890473
343UbiquitinationSCNCLLLKVNQIGSV
CCCEEEEEHHHHCCH
38.8221890473
349PhosphorylationLKVNQIGSVTESLQA
EEHHHHCCHHHHHHH
27.7420068231
351PhosphorylationVNQIGSVTESLQACK
HHHHCCHHHHHHHHH
22.8920068231
353PhosphorylationQIGSVTESLQACKLA
HHCCHHHHHHHHHHH
19.2020068231
357S-palmitoylationVTESLQACKLAQANG
HHHHHHHHHHHHHCC
2.0929575903
358AcetylationTESLQACKLAQANGW
HHHHHHHHHHHHCCC
50.2823954790
358SuccinylationTESLQACKLAQANGW
HHHHHHHHHHHHCCC
50.2823954790
358UbiquitinationTESLQACKLAQANGW
HHHHHHHHHHHHCCC
50.28-
368SulfoxidationQANGWGVMVSHRSGE
HHCCCEEEEECCCCC
1.9530846556
370PhosphorylationNGWGVMVSHRSGETE
CCCEEEEECCCCCCC
8.62-
372MethylationWGVMVSHRSGETEDT
CEEEEECCCCCCCCC
38.56-
373PhosphorylationGVMVSHRSGETEDTF
EEEEECCCCCCCCCH
35.2430278072
376PhosphorylationVSHRSGETEDTFIAD
EECCCCCCCCCHHHH
42.5630278072
379PhosphorylationRSGETEDTFIADLVV
CCCCCCCCHHHHHHH
15.6530278072
389S-palmitoylationADLVVGLCTGQIKTG
HHHHHHHHCCCCCCC
3.1026865113
390PhosphorylationDLVVGLCTGQIKTGA
HHHHHHHCCCCCCCC
36.8428060719
394UbiquitinationGLCTGQIKTGAPCRS
HHHCCCCCCCCCCCH
32.78-
395PhosphorylationLCTGQIKTGAPCRSE
HHCCCCCCCCCCCHH
39.9623882029
4062-HydroxyisobutyrylationCRSERLAKYNQLLRI
CCHHHHHHHHHHHHH
49.69-
406AcetylationCRSERLAKYNQLLRI
CCHHHHHHHHHHHHH
49.6925825284
406UbiquitinationCRSERLAKYNQLLRI
CCHHHHHHHHHHHHH
49.6921890473
406 (in isoform 1)Ubiquitination-49.6921890473
406UbiquitinationCRSERLAKYNQLLRI
CCHHHHHHHHHHHHH
49.6921890473
406UbiquitinationCRSERLAKYNQLLRI
CCHHHHHHHHHHHHH
49.6921890473
412MethylationAKYNQLLRIEEELGS
HHHHHHHHHHHHHHH
42.75-
419PhosphorylationRIEEELGSKAKFAGR
HHHHHHHHHHHHCCC
41.9023401153
420N6-malonyllysineIEEELGSKAKFAGRN
HHHHHHHHHHHCCCC
54.52-
4202-HydroxyisobutyrylationIEEELGSKAKFAGRN
HHHHHHHHHHHCCCC
54.52-
420AcetylationIEEELGSKAKFAGRN
HHHHHHHHHHHCCCC
54.5219608861
420MalonylationIEEELGSKAKFAGRN
HHHHHHHHHHHCCCC
54.5226320211
420SuccinylationIEEELGSKAKFAGRN
HHHHHHHHHHHCCCC
54.52-
420UbiquitinationIEEELGSKAKFAGRN
HHHHHHHHHHHCCCC
54.5219608861
420 (in isoform 1)Ubiquitination-54.5221890473
422AcetylationEELGSKAKFAGRNFR
HHHHHHHHHCCCCCC
39.2172614587
422UbiquitinationEELGSKAKFAGRNFR
HHHHHHHHHCCCCCC
39.21-
434AcetylationNFRNPLAK-------
CCCCCCCC-------
69.4311923871

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
44YPhosphorylationKinaseSRCP12931
GPS
44YPhosphorylationKinaseSRC64-PhosphoELM
115SPhosphorylationKinaseULK1O75385
PSP
282SPhosphorylationKinaseULK1O75385
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ENOA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ENOA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PLMN_HUMANPLGphysical
11169399
TPC2A_HUMANTRAPPC2physical
11134351
TPC2B_HUMANTRAPPC2physical
11134351
HDAC1_HUMANHDAC1physical
10403782
NS1BP_HUMANIVNS1ABPphysical
17996313
PGK1_HUMANPGK1physical
22939629
G3P_HUMANGAPDHphysical
22939629
TPIS_HUMANTPI1physical
22939629
FLNC_HUMANFLNCphysical
22939629
PPIA_HUMANPPIAphysical
22939629
ITPA_HUMANITPAphysical
22939629
ENOB_HUMANENO3physical
22939629
IC1_HUMANSERPING1physical
21988832
SZRD1_HUMANSZRD1physical
22658674
NUDC_HUMANNUDCphysical
22658674
RCC1_HUMANRCC1physical
22658674
SYYC_HUMANYARSphysical
22658674
LRC42_HUMANLRRC42physical
22658674
RM37_HUMANMRPL37physical
22658674
DPH5_HUMANDPH5physical
22658674
GSTM3_HUMANGSTM3physical
22658674
STRP1_HUMANSTRIP1physical
22658674
H2A2B_HUMANHIST2H2ABphysical
22658674
C42S1_HUMANCDC42SE1physical
22658674
POGZ_HUMANPOGZphysical
22658674
LMNA_HUMANLMNAphysical
22658674
HDGF_HUMANHDGFphysical
22658674
DEDD_HUMANDEDDphysical
22658674
TM40L_HUMANTOMM40Lphysical
22658674
STX6_HUMANSTX6physical
22658674
SRSF7_HUMANSRSF7physical
22658674
FBLN3_HUMANEFEMP1physical
22658674
TCPH_HUMANCCT7physical
22658674
RPA1_HUMANPOLR1Aphysical
22658674
BIN1_HUMANBIN1physical
22658674
IWS1_HUMANIWS1physical
22658674
NAB1_HUMANNAB1physical
22658674
ABI2_HUMANABI2physical
22658674
EF1B_HUMANEEF1B2physical
22658674
ARPC4_HUMANARPC4physical
22658674
DHX30_HUMANDHX30physical
22658674
QRIC1_HUMANQRICH1physical
22658674
IFRD2_HUMANIFRD2physical
22658674
THOC7_HUMANTHOC7physical
22658674
DHX15_HUMANDHX15physical
22658674
HNRPD_HUMANHNRNPDphysical
22658674
FAT4_HUMANFAT4physical
22658674
DCLK2_HUMANDCLK2physical
22658674
ERAP1_HUMANERAP1physical
22658674
RPGF6_HUMANRAPGEF6physical
22658674
GRP75_HUMANHSPA9physical
22658674
STK10_HUMANSTK10physical
22658674
SYFM_HUMANFARS2physical
22658674
H4_HUMANHIST1H4Iphysical
22658674
KLDC3_HUMANKLHDC3physical
22658674
MYO6_HUMANMYO6physical
22658674
ASCC3_HUMANASCC3physical
22658674
HDAC2_HUMANHDAC2physical
22658674
FBX5_HUMANFBXO5physical
22658674
SCAF8_HUMANSCAF8physical
22658674
OSBL3_HUMANOSBPL3physical
22658674
ODO1_HUMANOGDHphysical
22658674
TENS3_HUMANTNS3physical
22658674
GATD1_HUMANGATAD1physical
22658674
MPPB_HUMANPMPCBphysical
22658674
NU205_HUMANNUP205physical
22658674
XPO7_HUMANXPO7physical
22658674
SCAR3_HUMANSCARA3physical
22658674
MTFR1_HUMANMTFR1physical
22658674
1433Z_HUMANYWHAZphysical
22658674
CH033_HUMANC8orf33physical
22658674
KANK1_HUMANKANK1physical
22658674
MPDZ_HUMANMPDZphysical
22658674
ACOC_HUMANACO1physical
22658674
UBAP1_HUMANUBAP1physical
22658674
ANXA1_HUMANANXA1physical
22658674
DPOE3_HUMANPOLE3physical
22658674
HNRH3_HUMANHNRNPH3physical
22658674
FBW1A_HUMANBTRCphysical
22658674
NP1L4_HUMANNAP1L4physical
22658674
COPB_HUMANCOPB1physical
22658674
CATA_HUMANCATphysical
22658674
PRP19_HUMANPRPF19physical
22658674
CPSF7_HUMANCPSF7physical
22658674
SYT12_HUMANSYT12physical
22658674
CPT1A_HUMANCPT1Aphysical
22658674
NUMA1_HUMANNUMA1physical
22658674
ENDD1_HUMANENDOD1physical
22658674
YAP1_HUMANYAP1physical
22658674
DCPS_HUMANDCPSphysical
22658674
CNDD3_HUMANNCAPD3physical
22658674
VP26B_HUMANVPS26Bphysical
22658674
MPRD_HUMANM6PRphysical
22658674
LIPB1_HUMANPPFIBP1physical
22658674
LTMD1_HUMANLETMD1physical
22658674
RBMS2_HUMANRBMS2physical
22658674
NET4_HUMANNTN4physical
22658674
KIME_HUMANMVKphysical
22658674
RNF10_HUMANRNF10physical
22658674
RHOF_HUMANRHOFphysical
22658674
STX2_HUMANSTX2physical
22658674
MPP8_HUMANMPHOSPH8physical
22658674
DIAP3_HUMANDIAPH3physical
22658674
MBNL2_HUMANMBNL2physical
22658674
NNRD_HUMANCARKDphysical
22658674
PNPH_HUMANPNPphysical
22658674
IPO4_HUMANIPO4physical
22658674
RBM25_HUMANRBM25physical
22658674
ERG28_HUMANC14orf1physical
22658674
SKAP_HUMANKNSTRNphysical
22658674
TP53B_HUMANTP53BP1physical
22658674
MYO1E_HUMANMYO1Ephysical
22658674
KIF23_HUMANKIF23physical
22658674
PTN9_HUMANPTPN9physical
22658674
SNR25_HUMANSNRNP25physical
22658674
CHIP_HUMANSTUB1physical
22658674
TXD11_HUMANTXNDC11physical
22658674
VPS35_HUMANVPS35physical
22658674
E2F4_HUMANE2F4physical
22658674
NFAC3_HUMANNFATC3physical
22658674
CYB5B_HUMANCYB5Bphysical
22658674
PDPR_HUMANPDPRphysical
22658674
SYAC_HUMANAARSphysical
22658674
WDR81_HUMANWDR81physical
22658674
CHD3_HUMANCHD3physical
22658674
RAB34_HUMANRAB34physical
22658674
MY18A_HUMANMYO18Aphysical
22658674
ACACA_HUMANACACAphysical
22658674
THA_HUMANTHRAphysical
22658674
SMCE1_HUMANSMARCE1physical
22658674
DHX8_HUMANDHX8physical
22658674
S2539_HUMANSLC25A39physical
22658674
ANR40_HUMANANKRD40physical
22658674
LC7L3_HUMANLUC7L3physical
22658674
NPL4_HUMANNPLOC4physical
22658674
GIPC3_HUMANGIPC3physical
22658674
HNRPM_HUMANHNRNPMphysical
22658674
CRLF1_HUMANCRLF1physical
22658674
MED29_HUMANMED29physical
22658674
SPT5H_HUMANSUPT5Hphysical
22658674
FBRL_HUMANFBLphysical
22658674
PPP5_HUMANPPP5Cphysical
22658674
ISOC2_HUMANISOC2physical
22658674
NOP56_HUMANNOP56physical
22658674
XRN2_HUMANXRN2physical
22658674
OFUT1_HUMANPOFUT1physical
22658674
CP250_HUMANCEP250physical
22658674
ZNFX1_HUMANZNFX1physical
22658674
ATP5J_HUMANATP5Jphysical
22658674
SUMO3_HUMANSUMO3physical
22658674
CLH2_HUMANCLTCL1physical
22658674
PIPNB_HUMANPITPNBphysical
22658674
NIPS1_HUMANNIPSNAP1physical
22658674
SF3A1_HUMANSF3A1physical
22658674
XRCC6_HUMANXRCC6physical
22658674
NB5R3_HUMANCYB5R3physical
22658674
TXLNG_HUMANTXLNGphysical
22658674
SH3K1_HUMANSH3KBP1physical
22658674
PRDX4_HUMANPRDX4physical
22658674
DPOLA_HUMANPOLA1physical
22658674
EBP_HUMANEBPphysical
22658674
MORC4_HUMANMORC4physical
22658674
BAP31_HUMANBCAP31physical
22658674
ALDR_HUMANAKR1B1physical
26344197
AK1BF_HUMANAKR1B15physical
26344197
ATP5J_HUMANATP5Jphysical
26344197
CALR_HUMANCALRphysical
26344197
CATA_HUMANCATphysical
26344197
DUT_HUMANDUTphysical
26344197
EF2_HUMANEEF2physical
26344197
FABP5_HUMANFABP5physical
26344197
FKB1A_HUMANFKBP1Aphysical
26344197
FKB1B_HUMANFKBP1Bphysical
26344197
FKBP7_HUMANFKBP7physical
26344197
G6PI_HUMANGPIphysical
26344197
MIF_HUMANMIFphysical
26344197
NIT2_HUMANNIT2physical
26344197
PDIA1_HUMANP4HBphysical
26344197
PEF1_HUMANPEF1physical
26344197
PGAM1_HUMANPGAM1physical
26344197
MYP2_HUMANPMP2physical
26344197
PUS7_HUMANPUS7physical
26344197
SORCN_HUMANSRIphysical
26344197
TALDO_HUMANTALDO1physical
26344197
TPIS_HUMANTPI1physical
26344197
THIO_HUMANTXNphysical
26344197
UCHL3_HUMANUCHL3physical
26344197
FBXW7_HUMANFBXW7physical
26097998

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ENOA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-60; LYS-64; LYS-71;LYS-89; LYS-126; LYS-193; LYS-199; LYS-228; LYS-233; LYS-256; LYS-281;LYS-285; LYS-406 AND LYS-420, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-71, AND MASS SPECTROMETRY.
Malonylation
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-233 AND LYS-420.
N6-malonyllysine
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-233 AND LYS-420.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; TYR-44; SER-272 ANDTHR-390, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254 AND SER-263, ANDMASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-57 AND SER-63, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-72, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44 AND TYR-287, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44 AND TYR-287, AND MASSSPECTROMETRY.

TOP